abstract |
The present invention relates to a compound J of formula (1) and a 3TC compound of the HIV reverse transcriptase inhibitor of formula (2) and optionally a compound of the art which can be used as a nucleoside type HIV reverse transcriptase inhibitor, AZT, ddI or ddC, or from a pharmaceutical point of view. The stone combinations of the present invention are useful for inhibiting HIV protease, inhibiting HIV reverse transcriptase, preventing or treating HIV infection, and treating or preventing acquired immune deficiency syndrome and AIDS-related stone complex disease (ARC). The stone combinations according to the invention can be added simultaneously or alternately. The invention also relates to methods of treatment with stone combinations |